<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03775512</url>
  </required_header>
  <id_info>
    <org_study_id>BWI_2017_07</org_study_id>
    <nct_id>NCT03775512</nct_id>
  </id_info>
  <brief_title>Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation</brief_title>
  <acronym>Q-FFICIENCY</acronym>
  <official_title>Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation (PVI) in Subjects With PAF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biosense Webster, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biosense Webster, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, non-randomized, pre-market clinical evaluation of the QDOT MICRO™ Catheter to
      demonstrate the safety and effectiveness when compared to an historical control performance
      goal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, non-randomized, pre-market clinical evaluation of the QDOT MICRO™ Catheter to
      demonstrate the safety and effectiveness when compared to an historical control performance
      goal.

      the trial has two arms: main arm and second arm (variable flow). The main arm will enroll 185
      subjects and second arm will enroll 92 subjects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2019</start_date>
  <completion_date type="Anticipated">April 4, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Safety: Incidence of early onset PAEs</measure>
    <time_frame>7 days of the procedure</time_frame>
    <description>Incidence of early onset primary adverse events (PAE) related to the device or procedure. Occurrence of Primary AEs within 7 days of an ablation procedure.
Primary adverse events include the following conditions
Death
Atrio-esophageal fistula
Cardiac Tamponade/Perforation
Myocardial infarction (MI)
Stroke / Cerebrovascular accident (CVA)
Thromboembolism
Transient Ischemic Attack
Phrenic Nerve Injury/Diaphragmatic paralysis
Heart block
PV stenosis
Pulmonary edema (Respiratory Insufficiency)
Vagal Nerve Injury
Pericarditis
Major vascular access complication / bleeding</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from atrial tachyarrhythmias recurrence</measure>
    <time_frame>3- 12 months</time_frame>
    <description>The primary effectiveness endpoint is defined as the freedom from documented atrial fibrillation, atrial flutter and atrial tachycardia recurrence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Unanticipated Adverse Device Effects (UADEs)</measure>
    <time_frame>12 months</time_frame>
    <description>Incidence of Unanticipated Adverse Device Effects (UADEs)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">277</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Main Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be ablated with the QDOT Micro Catheter for Pulmonary Vein Isolation with nMARQ RF Generator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Second Arm (variable flow)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects will be treated with QDOT Micro catheter with variable flow nMARQ RF generator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RF Ablation with QDOT Micro</intervention_name>
    <description>Subjects will be ablated using QDOT Micro catheter</description>
    <arm_group_label>Main Arm</arm_group_label>
    <arm_group_label>Second Arm (variable flow)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Symptomatic paroxysmal AF with one electrocardiographically documented AF episode
             within 6 months prior to enrollment and a a physician's note indicating recurrent
             self-terminating AF within 7 days . Documentation may include electrocardiogram (ECG);
             Transtelephonic monitoring (TTM), Holter monitor or telemetry strip.

          -  Failed at least one Class I or Class III antiarrhythmic drug as evidenced by recurrent
             symptomatic AF, contraindicated, or intolerable to the AAD.

          -  Age 18 years or older.

        Key Exclusion Criteria:

          -  Previous surgical or catheter ablation for atrial fibrillation.

          -  AF secondary to electrolyte imbalance, thyroid disease, or reversible or non-cardiac
             cause.

          -  Previously diagnosed with persistent or long-standing persistent AF and/or Continuous
             AF &gt; 7 days.

          -  Valve repair or replacement or presence of a prosthetic valve.

          -  CABG surgery within the past 6 months (180 days).

          -  Any carotid stenting or endarterectomy within the past 6 months.

          -  Coronary artery bypass grafting, cardiac surgery, or valvular cardiac surgical
             procedure within the past 6 months.

          -  Documented left atrium (LA) thrombus within 1 day prior to the index procedure.

          -  Documented LA size &gt; 50 mm.

          -  Documented LVEF &lt; 40%.

          -  Contraindication to anticoagulation (e.g., heparin).

          -  MI/PCI within the past 2 months.

          -  Documented thromboembolic event (including transient ischemic attack) within the past
             12 months.

          -  Uncontrolled heart failure or New York Heart Association (NYHA) function class III or
             IV.

          -  Awaiting cardiac transplantation or other cardiac surgery within the next 12 months.

          -  Presence of implanted pacemaker or implantable cardioverter defibrillator (ICD).

          -  Women who are pregnant, lactating, or who are of child bearing age and plan on
             becoming pregnant during the course of the clinical investigation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emile Daoud</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Osorio</last_name>
    <role>Principal Investigator</role>
    <affiliation>Grandview Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francis Marchlinksi</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Cutler</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intermountain Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Natale</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Cardiac Arrhythmia Research Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Melby</last_name>
    <role>Principal Investigator</role>
    <affiliation>Abbott Northwestern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miguel Valderabanno</last_name>
    <role>Principal Investigator</role>
    <affiliation>Houston Methodist</affiliation>
  </overall_official>
  <overall_official>
    <last_name>George Monir</last_name>
    <role>Principal Investigator</role>
    <affiliation>AdventHealth</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Craig Delaughter</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Heart Health and Vascular</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Liu</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Presbyterian Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Saumil Oza</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ascension St. Vincent's</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ayman Hussein</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Fishel</last_name>
    <role>Principal Investigator</role>
    <affiliation>JFK Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth Ellenbogen</last_name>
    <role>Principal Investigator</role>
    <affiliation>VCU</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gery Tomassoni</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baptist Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tristram Bahnson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chris Ellis</last_name>
    <role>Principal Investigator</role>
    <affiliation>VUMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emerson Liu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Allegheny College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Wilber</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loyola University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moussa Mansour</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mass General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Srinivas Dukkipati</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hugh McElderry</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Hranitzky</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wakemed Heart and Vascular</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Larry Chinitz</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luigi DiBiase</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grandview Medical Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Cooper, RN</last_name>
      <phone>205-971-7484</phone>
      <email>jennifer.cooper@grandviewhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ascension St. Vincent's</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baptist Health</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital Clinic</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Nauertz, BS, CRC</last_name>
      <phone>612-863-1661</phone>
      <email>andrew.nauertz@allina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center - Albert Einstein</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mt. Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>WakeMed Heart &amp; Vascular</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Penn Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Texas Heart Health and Vascular</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. David's - TCAR</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 23, 2018</study_first_submitted>
  <study_first_submitted_qc>December 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2018</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

